|
Hi,
Big Pharma companies are already trying to profit from drugs to treat or prevent coronavirus infection -- and we need your help to stop them.
Last week Gilead Sciences was caught attempting to get exclusive rights to one drug that has shown promise in treating covid-19. Under intense public pressure they backed off, but they still have the ability to raise the price high and gouge everyone for desperately needed medicine -- just like they have with insulin.1
The Intercept discovered that Gilead had applied for, and the FDA had given them, exclusive marketing rights for remdesivir, an anti-viral drug that early studies have shown may help fight covid-19.
That means Gilead could have had a monopoly on an essential drug in the fight against the coronavirus pandemic. Even now that they've backed off on the exclusive rights, they still can charge a huge sum for the drug.
But there's a solution, one that the federal government regularly used in the 1960s and 1970s. Under a federal law known as Section 1498, the government can override a patent at any time as long as the company receives "reasonable compensation."
This gives the government critical leverage to negotiate lower prices. And the government could even start producing lifesaving treatments itself under the Defense Production Act.
Will you help use that leverage to save lives and stop Big Pharma from gouging people?
Thanks for taking action,
Robert and the team at Demand Progress
Sources:
1. The Intercept, "Gildead Sciences Backs Off Monopoly Claim for Promising Coronavirus Drug," March 25, 2020.
PAID FOR BY DEMAND PROGRESS (DemandProgress.org) and not authorized by any candidate or candidate's committee. Contributions are not deductible as charitable contributions for federal income tax purposes. Join our online community on Facebook or Twitter.
You can unsubscribe from this list at any time.